October 19th, 2026Most Bariatric Surgery Candidates Meet New Clinical Obesity CriteriaNearly 3 in 4 bariatric surgery candidates had clinical obesity, a phenotype that BMI alone did not distinguish from preclinical obesity.Read more
October 19th, 2026FDA Approves First At-Home Subcutaneous Thyroid Eye Disease TreatmentSatralizumab, a first-in-class IL-6 receptor inhibitor, was approved for adults with thyroid eye disease based on the phase 3 SatraGO program.Read more
October 19th, 2026AAO 2026: Closing the Screening Gap in Diabetic RetinopathyThe meeting covered several topics in eye care, including how artificial intelligence (AI) can play a part in eye care.Read more
October 19th, 2026Intensive BP Lowering Cuts CV Events Regardless of CKD StatusA meta-analysis of 27 trials found a 15% cardiovascular risk reduction per 10-mm Hg lower systolic BP, with no added risk of kidney failure.Read more
October 19th, 2026Higher Platelet-to-Neutrophil Ratio Linked With Lower MASLD OddsA higher PNR is associated with lower odds of MASLD and advanced liver fibrosis, but further studies are needed to validate findings.Read more
October 19th, 2026New CHEST Guidelines Offer a Road Map for BronchiectasisSpeakers at CHEST 2026 walked through the first CHEST guideline for non-CF adult bronchiectasis, including which preventive therapy to start first.Read more
October 18th, 2026CHEST Highlights Practice-Changing COPD Therapy and StrategiesOn the opening day of CHEST 2026, the organization's flagship journal highlights a trio of key papers with practice-changing results for COPD.Read more
October 18th, 2026CHEST Investigations Explore COPD Guideline Adherence, Adding Ensifentrine, and Use of AI in EducationSelected presentations from “Reframing COPD: Phenotypes, Outcomes, Therapeutics, and the Future of Care Delivery,” a session on the opening day of CHEST 2026.Read more